Skip to main content
. 2018 Apr 27;4(2):2055217318773112. doi: 10.1177/2055217318773112

Table 2.

Primary outcome. The number and percentage of participants with progression to multiple sclerosis (MS) at 3, 6 and 12 months.

Time of satisfyingMS criteria Phototherapy Controls Fisher’sexact test (two-sided)p value
Three months 5/10 (50%) 5/9 (56%) 1.00
Six months 5/10 (50%) 7/9 (78%) 0.35
Twelve months 7/10 (70%) 9/9 (100%) 0.21